This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Audiological Devices Industry

Industry Value Chain II-16

Table 7: Hearing Aid Industry Value Chain: Cost and Value

Addition by Segment (includes corresponding Graph/Chart) II-16

Poor Levels of Hearing Aid Penetration Promise Bright Prospects II-16

Table 8: World Hearing Loss Population Breakdown by Severity:

2011 (includes corresponding Graph/Chart) II-17

Table 9: Penetration of Hearing Systems: Breakdown for Usersand Non-Users of Hearing Systems (includes correspondingGraph/Chart) II-17

Table 10: World Hearing Aid Adoption Rate for Years 2006-2015

(includes corresponding Graph/Chart) II-18

Table 11: World Adoption Rate of Hearing Aids by Region - US,EU, Asia-Pacific and Rest of World for Years 2005, 2010, 2015 &2020 (includes corresponding Graph/Chart) II-18

Table 12: Hearing Aid Penetration Rate in Select Countries

Worldwide (includes corresponding Graph/Chart) II-19

Subsidy/Reimbursement Scenario for Hearing Aids II-19

A Review of Subsidy/Reimbursement System for Hearing Aids in

Select Regional Markets II-19

3. COCHLEAR IMPLANTS - MARKET REVIEW II-21Cochlear Implants Gain Visibility II-21Low Penetration of CI Implants - A Concern and an Opportunity II-21Reimbursement of Cochlear Implants II-22Cochlear Implants Reimbursements: A Review (Recent Past) II-22Adult Patient Segment - the Next Growth Avenue for CochlearImplants II-22Emerging Markets - Will They Offset Slowing Sales Growth inDeveloped Markets? II-22Bilateral Implantation Catching Up II-23Diversity Exists in Adoption of Regional Binaural Hearing Devices II-23Robust Prospects for BAHI in Developed Markets II-24

4. COMPETITIVE LANDSCAPE II-25

Hearing Aids Market II-25

Handful of Players Dominate the Marketplace II-25

Table 13: Leading Players in the Global Hearing Aid Market

by Value (2011): Percentage Breakdown of Revenues for

Sonova, W. Demant, Starkey, Siemens, GN ReSound and Others

(includes corresponding Graph/Chart) II-25

Table 14: Leading Players in the Global Hearing Aid Marketby Volume (2011): Percentage Breakdown of Volume Sales forSonova, W. Demant, Siemens, GN ReSound, Widex and Others(includes corresponding Graph/Chart) II-25Hearing Aids Market: Products and Distribution Presence ofKey Competitors II-26Hearing Aid Markets Witnesses Shuffle in Rankings II-26Consolidation Activity Continues in the Hearing Aid Industry II-26Consolidation Activity in the Hearing Aids Industry: SelectKey Acquisitions 2006-2012 II-27Strong Portfolio Pushes Sonova to the Top II-28InSound's Acquisition to Boost Sonova's Hearing Aids Sales II-28GN ReSound Pins Hopes on Resound Alera II-28The Road Ahead for Siemens II-29Product Diversification - the New Mantra to Beat Competition II-29Vertical Integration Catches Impetus in Hearing Aid Industry II-29Higher R&D Costs and Patent Situation II-30Measurement/Testing Devices II-30Competition in Cochlear Implants Market II-30Table 15: Leading Players in the Global Cochlear ImplantMarket (2009-2011): Percentage Breakdown of Unit Sales forCochlear, Med El, Advanced Bionics and Neurelec (includescorresponding Graph/Chart) II-31Cochlear Running Virtual Monopoly in the BAHI Market II-31Competitive Assessment for Future II-32Sonova's Cochlear Implants Market - Marred with Recalls II-32New Products to Expand Sonova's Share in Hearing Implant Market II-32Cost advantages to Assist Sonova in CI Implants II-33Advanced Bionics to Make Further Advances in Implants Market II-33Chinese Manufacturers Make a Foray in to Cochlear ImplantsMarket II-33

3 of 20

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,647.67 +51.32 0.29%
S&P 500 2,066.13 +8.49 0.41%
NASDAQ 4,986.0190 +27.5510 0.56%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs